Bigbear Pharmaceutical·Medication Guide

• What should I do if I missed using loratinib?

  Loratinib only needs to be taken once a day:If you realize you forgot to take your medication on the same day, you should take one immediately.If you ···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 73

• After use instructions of Lorlatinib

  The following points should be noted when using loratinib: First, it is essential to strictly follow the doctor's instructions and regularly monit···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 74

• What are the adverse reactions of loratinib?

  What are the adverse reactions of loratinib?Everyone's physical condition is different, and the possible adverse reactions may vary. Pay close att···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 73

• What are the available dosage forms and strengths of loratinib?

  What are the available dosage forms and strengths of loratinib?Loratinib is currently only available in tablet form, with two different strengths:25mg···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 73

• ​Which drugs may interact with loratinib?

  Which drugs may interact with loratinib?Special attention should be paid to interactions with other medications during treatment.Potent CYP3A inducers···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 73

• Who should use loratinib with caution?

  Who should use loratinib with caution?The following four groups of people are at higher risk when using this medication and need to exercise special c···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 73

• What medications are commonly used in conjunction with loratinib?

  What medications are commonly used in conjunction with loratinib?Because targeted therapies carry the risk of interactions, patients should not self-m···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 72

• Function and efficacy of Lorlatinib

  Function and efficacy ofLorlatinibLoratinib is a targeted therapy drug for a specific type of lung cancer. Its main component is an anaplastic lymphom···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 73

• How Much Does Capmatinib Cost Per Month? Breaking Down the Annual Treatment Expense

  Carmatinib is a targeted therapy for non-small cell lung cancer with MET exon 14 skipping mutations. For patients using this drug, the most crucial co···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 71

• Is Capmatinib Covered by Insurance? Navigating Medicare and Patient Assistance Programs

  Carmatinib (Tabrecta) is a highly selective MET receptor tyrosine kinase inhibitor that specifically inhibits the phosphorylation of MET receptors and···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 73

• Ixazomib Generic Availability 2026: Will Prices Drop Soon? Latest Updates & Cost Outlook

  Ixazomib, a novel targeted therapy drug, inhibits the activity of the proteasome, blocking the growth and proliferation of tumor cells, providing an i···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 73

• How to Save Money on Ixazomib: Patient Assistance Programs & Prescription Discounts in 2026

  Ixazomib is an oral proteasome inhibitor primarily used in the clinical treatment of multiple myeloma. As a novel targeted therapy, it blocks the grow···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 71

• FDA Approves Lenvima (lenvatinib) for the Treatment of Patients with Advanced Renal Cell Carcinoma

  Approval AnnouncementWOODCLIFF LAKE, N.J., May 13, 2016 /PRNewswire/ -- Eisai Inc. announced that the U.S. Food and Drug Administration (FDA) has appr···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 72

• FDA Approves Lenvima (lenvatinib) for First-line Treatment of Unresectable Hepatocellular Carcinoma

  Approval AnnouncementWoodcliff Lake, NJ and Kenilworth, NJ, Aug. 16, 2018 – Eisai Inc. and Merck (NYSE: MRK, known as MSD outside the U.S. and Canada)···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 70

• FDA Approves Keytruda (pembrolizumab) Plus Lenvima (lenvatinib) Combination for Certain Advanced End

  Approval AnnouncementKENILWORTH, N.J., & WOODCLIFF LAKE, N.J.-- September 17, 2019 -- Merck (NYSE: MRK, known as MSD outside the U.S. and Canada) ···【Read More】

  Update: 2026-03-13Source: Haiou HealthViews: 71